ReviewFrontiers in cardiovascular medicine2023

Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins.

K Vijayaraghavan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.